Contact: Mrs Ann Marie Corcoran
Email: [email protected]
Grifols is a global company that since 1909 has enhanced the health and well-being of people around the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services in more than 100 countries.
Grifols Worldwide Operations Ltd. was established in 2013 in Dublin, Ireland. It serves as the management center for the global Bioscience Division overseeing treasury, risk management, supply and demand planning, regulatory, R&D and commercial functions.
It also serves as a hub for labeling, packing, final conditioning and distribution of finished plasma products to Grifols' worldwide network of commercial subsidiaries and distributors, with the exception of Spain and the United States. The site will also host an Albumin purification plant which is now under construction. www.grifols.com
8 jobs with Grifols
QC Microbiology Supervisor Maternity Leave Contract 12-month maternity contract position is required for the Albumin protein purification and aseptic
Packaging Technician3 cycle shifts12 hours Days and Nights €35,000 plus shift allowance Health Insurance, Pension , Great Place to Work Within this r
Payroll & HR Administration Specialist The Payroll & HR Admin Specialist is responsible for all the activities related to HR Administration, includin
Quality Control Administrator. QC Support Administrator is required for the QC Department of a new purification and aseptic manufacturing plant
The Packaging Line Supervisor is responsible for the coordination of the packaging technician team, smooth running of packaging equipment, adherence
INTEGRATED BUSINESS PLANNING ANALYST. Key responsibilities: Integrated business planning (IBP) data analytics and reporting.
Quality Assurance Packaging Manager Reporting directly to the Technical Director of Grifols Worldwide Operations (GWWO), the QA Packaging Manager will
Head of Aseptic FillingThe Head of Aseptic Filling will lead the Filling Department in the start-up, qualification and validation of the New Albumin F